Skip to content Skip to navigation

Phenomics Lab

High-throughput solutions for large-scale disease phenotyping.

We have established scalable, high-throughput phenotyping methods for characterizing human and mouse eye diseases. The mouse eye phenotype screening service is available to laboratories throughout the world. Through the development of cooperative laboratory networks, we hope to expand our screening effort.

Projects

We have established a scalable, multilevel, high-throughput phenotyping laboratory to identify mouse models for eye disease.

Capturing surgical events for careful clinical studies has always been a challenge.

News

Oct 19 2023 | Posted In: 20/20 Blog
  Palo Alto, CA — The eyes may be a window into the soul, but Stanford research scientists are now showing the eyes may also be a window into overall human health. 
Aug 9 2022 | Posted In: 20/20 Blog
 
Apr 18 2022 | Posted In: 20/20 Blog
Palo Alto, CA — A Wall Street Journal article on age-related retinal tears and detachments features an interview with Stanford’s Vinit Mahajan MD, PhD, professor of ophthalmology and vice chair for
Dec 10 2021 | Posted In: 20/20 Blog
Palo Alto, CA — In the operating room and clinic, Vinit Mahajan M.D., Ph.D., Stanford Ophthalmology vice chair for research and ChEM-H fellow, uses ocular drug implants (ODIs) to safely deliver steroids into the eye to treat a range of eye di
Nov 11 2021 | Posted In: 20/20 Blog
Palo Alto, CA —News outlets, fitness magazines, and health bloggers churn out hundreds of articles on the health benefits of exercise. And most people can tell you that exercise is an important factor in warding off heart disease, diabetes, cancer, and depression.

Publications

Telegenetics for inherited retinal diseases in the COVID-19 environment., Al-Moujahed, Ahmad, Kumar Aarushi, Chemudupati Teja, Tsang Stephen H., and Mahajan Vinit B. , Int J Retina Vitreous, 2021 Mar 29, Volume 7, Issue 1, p.25, (2021)
Molecular Characterization of a Rare Case of Bilateral Vitreoretinal T Cell Lymphoma through Vitreous Liquid Biopsy., Cani, Andi K., Toral Marcus A., Balikov Daniel A., Betz Bryan L., Hu Kevin, Liu Chia-Jen, Prifti Matthew V., Chinnaiyan Arul M., Tomlins Scott A., Mahajan Vinit B., et al. , Int J Mol Sci, 2021 Jun 05, Volume 22, Issue 11, (2021)
Liquid biopsy proteomics of uveal melanoma reveals biomarkers associated with metastatic risk., Velez, Gabriel, Nguyen Huy V., Chemudupati Teja, Ludwig Cassie A., Toral Marcus, Reddy Sunil, Mruthyunjaya Prithvi, and Mahajan Vinit B. , Mol Cancer, 2021 02 24, Volume 20, Issue 1, p.39, (2021)
Genetics of Uveitis., Cunningham, Emmett T., Pichi Francesco, Mahajan Vinit B., Rosenbaum James T., and Zierhut Manfred , Ocul Immunol Inflamm, 2021 Feb 17, Volume 29, Issue 2, p.215-218, (2021)
Metabolite therapy guided by liquid biopsy proteomics delays retinal neurodegeneration., Wert, Katherine J., Velez Gabriel, Kanchustambham Vijaya L., Shankar Vishnu, Evans Lucy P., Sengillo Jesse D., Zare Richard N., Bassuk Alexander G., Tsang Stephen H., and Mahajan Vinit B. , EBioMedicine, 2020 Feb 03, Volume 52, p.102636, (2020)
Quantitative Autofluorescence Following Gene Therapy With Voretigene Neparvovec., Levi, Sarah R., Oh Jin Kyun, de Carvalho Jose Ronaldo Li, Mahajan Vinit B., Tsang Stephen H., and Sparrow Janet R. , JAMA Ophthalmol, 2020 Jun 18, (2020)